KOCAA
PFE icon

Knights of Columbus Asset Advisors’s Pfizer PFE Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-456
Closed -$12.1K – 386
2024
Q4 		$12.1K Sell
456
-7,567
-94% -$205K ﹤0.01% 363
2024
Q3 		$232K Buy
+8,023
New +$234K 0.02% 305

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Knights of Columbus Asset Advisors's PFE Position: Q1 2025 in Review

Knights of Columbus Asset Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 456 shares — an estimated $12.1K sold.

Knights of Columbus Asset Advisors first reported a position in PFE in Q3 2024 and held it in 2 quarters. The position peaked at $232K in Q3 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Knights of Columbus Asset Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 456 Pfizer shares in Q1 2025, an estimated $12.1K.
  • Knights of Columbus Asset Advisors first reported a position in Pfizer in Q3 2024 and held it in 2 quarters.
  • Knights of Columbus Asset Advisors's Pfizer position peaked at $232K in Q3 2024.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2025, filed 7 May 2025.